Eltrombopag modulates the phenotypic evolution and potential immunomodulatory roles of monocytes/macrophages in immune thrombocytopenia

References

• Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017;16(6):1–9. doi: 10.1016/j.autrev.2017.04.012.
   PubMed Web of Science ®Google Scholar
• DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19(6):369–382. doi: 10.1038/s41577-019-0127-6.
   PubMed Web of Science ®Google Scholar
• Guilliams M, Mildner A, Yona S. Developmental and functional heterogeneity of monocytes. Immunity. 2018;49(4):595–613. doi: 10.1016/j.immuni.2018.10.005.
   PubMed Web of Science ®Google Scholar
• Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011;11(11):762–774. doi: 10.1038/nri3070.
   PubMed Web of Science ®Google Scholar
• Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2020;15:123–147. doi: 10.1146/annurev-pathmechdis-012418-012718.
   PubMed Web of Science ®Google Scholar
• Ehninger A, Trumpp A. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med. 2011;208(3):421–428. doi: 10.1084/jem.20110132.
   PubMed Web of Science ®Google Scholar
• Chow A, Lucas D, Hidalgo A, Méndez-Ferrer S, Hashimoto D, Scheiermann C, Battista M, Leboeuf M, Prophete C, van Rooijen N, et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med. 2011;208(2):261–271. doi: 10.1084/jem.20101688.
   PubMed Web of Science ®Google Scholar
• Yang F, Feng W, Wang H, Wang L, Liu X, Wang R, Chen C, Yang X, Zhang D, Ren Q, et al. Monocyte-Derived leukemia-associated macrophages facilitate extramedullary distribution of T-cell acute lymphoblastic leukemia cells. Cancer Res. 2020;80(17):3677–3691. doi: 10.1158/0008-5472.CAN-20-0034.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang D, Cui X, Dai Y, Wang C, Feng W, Lv X, Li Y, Wang L, Ru Y, et al. Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion. Oncogene. 2022;41(16):2303–2314. doi: 10.1038/s41388-022-02233-w.
   PubMed Web of Science ®Google Scholar
• Kuwana M, Okazaki Y, Ikeda Y. Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura. J Thromb Haemost. 2009;7(2):322–329. doi: 10.1111/j.1538-7836.2008.03161.x.
   PubMed Web of Science ®Google Scholar
• Saleh MN, Moore DL, Lee JY, LoBuglio AF. Monocyte-platelet interaction in immune and nonimmune thrombocytopenia. Blood. 1989;74(4):1328–1331. doi: 10.1182/blood.V74.4.1328.1328.
   PubMed Web of Science ®Google Scholar
• Liu X-G, Liu S, Feng Q, Liu X-N, Li G-S, Sheng Z, Chen P, Liu Y, Wei Y, Dong X-Y, et al. Thrombopoietin receptor agonists shift the balance of Fcγ receptors toward inhibitory receptor IIb on monocytes in ITP. Blood. 2016;128(6):852–861. doi: 10.1182/blood-2016-01-690727.
   PubMed Web of Science ®Google Scholar
• Ghanima W, Gernsheimer T, Kuter DJ. How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment. Blood. 2021;137(20):2736–2744. doi: 10.1182/blood.2021010968.
   PubMed Web of Science ®Google Scholar
• Cooper N, Ghanima W, Solomon CG. Immune Thrombocytopenia. N Engl J Med. 2019;381(10):945–955. doi: 10.1056/NEJMcp1810479.
   PubMed Web of Science ®Google Scholar
• Stasi R, Evangelista ML, Amadori S. Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura. Drugs. 2008;68(7):901–912. doi: 10.2165/00003495-200868070-00002.
   PubMed Web of Science ®Google Scholar
• Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB. Thrombopoietin receptor agonists: undefined years later. Haematologica. 2019;104(6):1112–1123. doi: 10.3324/haematol.2018.212845.
   PubMed Web of Science ®Google Scholar
• Markham A. Avatrombopag: a review in thrombocytopenia. Drugs. 2021;81(16):1905–1913. doi: 10.1007/s40265-021-01613-y.
   PubMed Web of Science ®Google Scholar
• Cheng G. Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile. Ther Adv Hematol. 2012;3(3):155–164. doi: 10.1177/2040620712442525.
   PubMedGoogle Scholar
• Bao W, Bussel JB, Heck S, He W, Karpoff M, Boulad N, Yazdanbakhsh K. Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood. 2010;116(22):4639–4645. doi: 10.1182/blood-2010-04-281717.
   PubMed Web of Science ®Google Scholar
• Li X, Zhong H, Bao W, Boulad N, Evangelista J, Haider MA, Bussel J, Yazdanbakhsh K. Defective regulatory B-cell compartment in patients with immune thrombocytopenia. Blood. 2012;120(16):3318–3325. doi: 10.1182/blood-2012-05-432575.
   PubMed Web of Science ®Google Scholar
• Di Paola A, Palumbo G, Merli P, Argenziano M, Tortora C, Strocchio L, Roberti D, Santoro C, Perrotta S, Rossi F. Effects of eltrombopag on in vitro macrophage polarization in pediatric immune thrombocytopenia. Int J Mol Sci. 2020;22(1):97. doi: 10.3390/ijms22010097.
   PubMed Web of Science ®Google Scholar
• Yang X, Feng W, Wang R, Yang F, Wang L, Chen S, Ru Y, Cheng T, Zheng G. Repolarizing heterogeneous leukemia-associated macrophages with more M1 characteristics eliminates their pro-leukemic effects. Oncoimmunology. 2018;7(4):e1412910. doi: 10.1080/2162402X.2017.1412910.
   PubMed Web of Science ®Google Scholar
• Kostic M, Zivkovic N, Cvetanovic A, Marjanović G. CD4+ T cell phenotypes in the pathogenesis of immune thrombocytopenia. Cell Immunol. 2020;351:104096. doi: 10.1016/j.cellimm.2020.104096.
   PubMed Web of Science ®Google Scholar
• Hao Y, Li Y, Li H, Lyu M, Zhang D, Fu R, Guan Y, Wang S, Sun B, Dou X, et al. Increased plasma sCXCL16 levels may have a relationship with Th1/Th2 imbalance in primary immune thrombocytopenia. Cytokine. 2017;99:124–131. doi: 10.1016/j.cyto.2017.08.024.
   PubMed Web of Science ®Google Scholar
• Semple JW, Rebetz J, Maouia A, Kapur R. An update on the pathophysiology of immune thrombocytopenia. Curr Opin Hematol. 2020;27(6):423–429. doi: 10.1097/MOH.0000000000000612.
   PubMed Web of Science ®Google Scholar
• Lavin Y, Mortha A, Rahman A, Merad M. Regulation of macrophage development and function in peripheral tissues. Nat Rev Immunol. 2015;15(12):731–744. doi: 10.1038/nri3920.
   PubMed Web of Science ®Google Scholar
• Guilliams M, Thierry GR, Bonnardel J, Bajenoff M. Establishment and maintenance of the macrophage Niche. Immunity. 2020;52(3):434–451. doi: 10.1016/j.immuni.2020.02.015.
   PubMed Web of Science ®Google Scholar
• Vrbensky JR, Nazy I, Clare R, Larché M, Arnold DM. T cell-mediated autoimmunity in immune thrombocytopenia. Eur J Haematol. 2022;108(1):18–27. doi: 10.1111/ejh.13705.
   PubMed Web of Science ®Google Scholar
• Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue macrophages. Immunity. 2014;41(1):21–35. doi: 10.1016/j.immuni.2014.06.013.
   PubMed Web of Science ®Google Scholar
• Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, De Nardo D, Gohel TD, Emde M, Schmidleithner L, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. 2014;40(2):274–288. doi: 10.1016/j.immuni.2014.01.006.
   PubMed Web of Science ®Google Scholar
• Ferrari SM, Fallahi P, Elia G, Ragusa F, Camastra S, Paparo SR, Giusti C, Gonnella D, Ruffilli I, Shoenfeld Y, et al. Novel therapies for thyroid autoimmune diseases: an update. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101366. doi: 10.1016/j.beem.2019.101366.
   PubMed Web of Science ®Google Scholar
• Karin N, Wildbaum G. The role of chemokines in shaping the balance between CD4(+) T cell subsets and its therapeutic implications in autoimmune and cancer diseases. Front Immunol. 2015;6:609. doi: 10.3389/fimmu.2015.00609.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang H, Liu R, Qian T, Liu J, Huang E, Lu Z, Zhao C, Wang L, Chu Y. Peyer’s patches-derived CD11b B cells recruit regulatory T cells through CXCL9 in dextran sulphate sodium-induced colitis. Immunology. 2018;155(3):356–366. doi: 10.1111/imm.12977.
   PubMed Web of Science ®Google Scholar
• Tang Z, Gao J, Wu J, Zeng G, Liao Y, Song Z, Liang X, Hu J, Hu Y, Liu M, et al. Human umbilical cord mesenchymal stromal cells attenuate pulmonary fibrosis via regulatory T cell through interaction with macrophage. Stem Cell Res Ther. 2021;12(1):397. doi: 10.1186/s13287-021-02469-5.
   PubMed Web of Science ®Google Scholar
• Zohar Y, Wildbaum G, Novak R, Salzman AL, Thelen M, Alon R, Barsheshet Y, Karp CL, Karin N. CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. J Clin Invest. 2018;128(3):1200–1201. doi: 10.1172/JCI120358.
   PubMed Web of Science ®Google Scholar
• Wing JB, Tanaka A, Sakaguchi S. Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity. 2019;50(2):302–316. doi: 10.1016/j.immuni.2019.01.020.
   PubMed Web of Science ®Google Scholar
• Lucchini E, Palandri F, Volpetti S, Vianelli N, Auteri G, Rossi E, Patriarca A, Carli G, Barcellini W, Celli M, et al. Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study. Br J Haematol. 2021;193(2):386–396. doi: 10.1111/bjh.17334.
   PubMed Web of Science ®Google Scholar
• Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017;6(2):16. doi: 10.3390/jcm6020016.
   PubMed Web of Science ®Google Scholar
• Lozano ML, Segú-Vergés C, Coma M, Álvarez-Roman MT, González-Porras JR, Gutiérrez L, Valcárcel D, Butta N. Elucidating the mechanism of action of the attributed immunomodulatory role of eltrombopag in primary immune thrombocytopenia: an in silico approach. Int J Mol Sci. 2021;22(13):6907. doi: 10.3390/ijms22136907.
   PubMed Web of Science ®Google Scholar
• Spitz AZ, Zacharioudakis E, Reyna DE, Garner TP, Gavathiotis E. Eltrombopag directly inhibits BAX and prevents cell death. Nat Commun. 2021;12(1):1134. doi: 10.1038/s41467-021-21224-1.
   PubMed Web of Science ®Google Scholar
• Schmiedel BJ, Singh D, Madrigal A, Valdovino-Gonzalez AG, White BM, Zapardiel-Gonzalo J, Ha B, Altay G, Greenbaum JA, McVicker G, et al. Impact of genetic polymorphisms on human immune cell gene expression. Cell. 2018;175(6):1701–1715. doi: 10.1016/j.cell.2018.10.022.
   PubMed Web of Science ®Google Scholar
• Monaco G, Lee B, Xu W, Mustafah S, Hwang YY, Carré C, Burdin N, Visan L, Ceccarelli M, Poidinger M, et al. RNA-Seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types. Cell Rep. 2019;26(6):1627–1640. doi: 10.1016/j.celrep.2019.01.041.
   PubMed Web of Science ®Google Scholar
• Sadallah S, Amicarella F, Eken C, Iezzi G, Schifferli JA. Ectosomes released by platelets induce differentiation of CD4+T cells into T regulatory cells. Thromb Haemost. 2014;112(12):1219–1229. doi: 10.1160/th14-03-0281.
   PubMed Web of Science ®Google Scholar
• Vlachodimitropoulou E, Chen Y-L, Garbowski M, Koonyosying P, Psaila B, Sola-Visner M, Cooper N, Hider R, Porter J. Eltrombopag: a powerful chelator of cellular or extracellular iron(iii) alone or combined with a second chelator. Blood. 2017;130(17):1923–1933. doi: 10.1182/blood-2016-10-740241.
   PubMed Web of Science ®Google Scholar
• Jais A, Einwallner E, Sharif O, Gossens K, T-H Lu T, Soyal SM, Medgyesi D, Neureiter D, Paier-Pourani J, Dalgaard K, et al. Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man. Cell. 2014;158(1):25–40. doi: 10.1016/j.cell.2014.04.043.
   PubMed Web of Science ®Google Scholar
• Wilkinson HN, Roberts ER, Stafford AR, Banyard KL, Matteucci P, Mace KA, Hardman MJ. Tissue iron promotes wound repair via M2 macrophage polarization and the chemokine (C-C Motif) ligands 17 and 22. Am J Pathol. 2019;189(11):2196–2208. doi: 10.1016/j.ajpath.2019.07.015.
   PubMed Web of Science ®Google Scholar
• Semple JW, Italiano JE, Freedman J. Platelets and the immune continuum. Nat Rev Immunol. 2011;11(4):264–274. doi: 10.1038/nri2956.
   PubMed Web of Science ®Google Scholar
• Vogel S, Rath D, Borst O, Mack A, Loughran P, Lotze MT, Neal MD, Billiar TR, Gawaz M. Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes. Biochem Biophys Res Commun. 2016;478(1):143–148. doi: 10.1016/j.bbrc.2016.07.078.
   PubMed Web of Science ®Google Scholar
• Carestia A, Mena HA, Olexen CM, Ortiz Wilczyñski JM, Negrotto S, Errasti AE, Gómez RM, Jenne CN, Carrera Silva EA, Schattner M. Platelets promote macrophage polarization toward pro-inflammatory phenotype and increase survival of septic mice. Cell Rep. 2019;28(4):896–908. doi: 10.1016/j.celrep.2019.06.062.
   PubMed Web of Science ®Google Scholar
• Saleh MN, Bussel JB, Cheng G, Meyer O, Bailey CK, Arning M, Brainsky A. Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. Blood. 2013;121(3):537–545. doi: 10.1182/blood-2012-04-425512.
   PubMed Web of Science ®Google Scholar